pawolook.livejournal.com/1244.html

Preview meta tags from the pawolook.livejournal.com website.

Linked Hostnames

2

Thumbnail

Search Engine Appearance

Google

https://pawolook.livejournal.com/1244.html

More on BSI-201 PARP Inhibitor

From Bloomberg News An experimental cancer drug made by Sanofi-Aventis SA helped patients with advanced breast tumors live more than 60 percent longer using a new method that stops diseased cells from healing themselves, a new study found. ... Sanofi will begin enrolling 400 patients in the next…



Bing

More on BSI-201 PARP Inhibitor

https://pawolook.livejournal.com/1244.html

From Bloomberg News An experimental cancer drug made by Sanofi-Aventis SA helped patients with advanced breast tumors live more than 60 percent longer using a new method that stops diseased cells from healing themselves, a new study found. ... Sanofi will begin enrolling 400 patients in the next…



DuckDuckGo

https://pawolook.livejournal.com/1244.html

More on BSI-201 PARP Inhibitor

From Bloomberg News An experimental cancer drug made by Sanofi-Aventis SA helped patients with advanced breast tumors live more than 60 percent longer using a new method that stops diseased cells from healing themselves, a new study found. ... Sanofi will begin enrolling 400 patients in the next…

  • General Meta Tags

    17
    • title
      More on BSI-201 PARP Inhibitor - pawolook — LiveJournal
    • X-UA-Compatible
      IE=Edge
    • Content-Type
      text/html;charset=utf-8
    • referrer
      no-referrer-when-downgrade
    • description
      From Bloomberg News An experimental cancer drug made by Sanofi-Aventis SA helped patients with advanced breast tumors live more than 60 percent longer using a new method that stops diseased cells from healing themselves, a new study found. ... Sanofi will begin enrolling 400 patients in the next…

  • Open Graph Meta Tags

    5
    • og:description
      From Bloomberg News An experimental cancer drug made by Sanofi-Aventis SA helped patients with advanced breast tumors live more than 60 percent longer using a new method that stops diseased cells from healing themselves, a new study found. ... Sanofi will begin enrolling 400 patients in the next…
    • og:image
      https://l-stat.livejournal.net/img/sign.png
    • og:title
      More on BSI-201 PARP Inhibitor
    • og:type
      article
    • og:url
      https://pawolook.livejournal.com/1244.html

  • Link Tags

    11
    • canonical
      https://pawolook.livejournal.com/1244.html
    • icon
      https://l-stat.livejournal.net/img/userinfo_v8.png?v=852
    • icon
      https://l-stat.livejournal.net/img/userinfo_v8.svg?v=17080?v=852
    • manifest
      /post_manifest.json
    • meta
      https://pawolook.livejournal.com/data/foaf

Links

38